Joel Charrow

The Gaucher Registry

Joel Charrow, Hans C. Andersson, Paige Kaplan et al. · Archives of Internal Medicine · 2000 · 585 citations

Life Sciences, Genetics, Molecular Genetics +17

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 556 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study

Robert Listernick, Joel Charrow, Mark J. Greenwald et al. · The Journal of Pediatrics · 1994 · 549 citations

Medicine, Neurology, Oncology +17

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

Neal J. Weinreb, Joel Charrow, Hans C. Andersson et al. · The American Journal of Medicine · 2002 · 541 citations

Life Sciences, Genetics, Pharmacotherapy +9

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease

Dominique P. Germain, Stephen Waldek, Maryam Banikazemi et al. · Journal of the American Society of Nephrology · 2007 · 435 citations

Medicine, Clinical Sciences, Pharmacotherapy +9